Synergistic Anti-Cd47 Therapy For Hematologic Cancers

Patent No. EP2477648 (titled "Synergistic Anti-Cd47 Therapy For Hematologic Cancers") was filed by The Board OF Trustees OF The Leland Stanford Junior University on Sep 15, 2010. The application was issued on Jul 20, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JG OPPOSITIONSApr 19, 2023FORD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2477648

THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Application Number
EP10817793A
Filing Date
Sep 15, 2010
Status
Opposition Rejected
May 2, 2025
Publication Date
Jul 20, 2022